Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Aspen Aerogels (ASPN) EBT (2016 - 2025)

Aspen Aerogels' EBT history spans 13 years, with the latest figure at -$75.2 million for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 771.86% year-over-year to -$75.2 million, compared with a TTM value of -$389.3 million through Dec 2025, down 2680.08%, and an annual FY2025 reading of -$389.3 million, down 2680.08% over the prior year.
  • EBT for Q4 2025 was -$75.2 million at Aspen Aerogels, down from -$5.7 million in the prior quarter.
  • The five-year high for EBT was $17.7 million in Q2 2024, with the low at -$300.2 million in Q1 2025.
  • Average EBT over 5 years is -$27.2 million, with a median of -$12.1 million recorded in 2021.
  • Year-over-year, EBT soared 2255.49% in 2024 and then tumbled 27719.56% in 2025.
  • Tracing ASPN's EBT over 5 years: stood at -$16.4 million in 2021, then surged by 41.3% to -$9.6 million in 2022, then skyrocketed by 94.59% to -$519000.0 in 2023, then soared by 2255.49% to $11.2 million in 2024, then tumbled by 771.86% to -$75.2 million in 2025.
  • Per Business Quant, the three most recent readings for ASPN's EBT are -$75.2 million (Q4 2025), -$5.7 million (Q3 2025), and -$8.2 million (Q2 2025).